Ruthsarian
Home
Sitemap
Q & A
Notice Board
PhEpi & PhV activities
Research Funding
Conferences & meetings
Recruitment
Links
Contact Us
Search Studies
The search criteria are non-mandatory. Therefore, not specifying any search criteria will return all database entries.
Status of Study:
Planned
Ongoing
Finalised
Title of Study:
Acronym:
Study type:
Active surveillance
Observational study
Clinical trial
Other
Study requested by a regulator:
Country of regulator:
EMA
Austria
Belgium
Bulgaria
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
Switzerland
United Kingdom
United States
Canada
Australia
Japan
Other:
Coordinating Study entity:
AIBILI
AMSP
BIPS
Biologics Studies Group
Bordeaux pharmacoepi
Brighton Collaboration
CEFAR
CEIFE
CEMKA
CHIP
CMNS
CRF_Campania
CSD MR UK
Cancer Epidemiology Unit, University of Oxford
CeVEAS
Centre for Pharmacoepidemiology (CPE)
Centre of Clinical Pharmacology for Drug Evaluat
Centre of Biostatistics-UL
Centro de Farmacovigilancia de Asturias
Clinical Pharmacology Department, HULP, UAM
Clinical Pharmacology Service, HUB/IDIBELL
Clinical Pharmacology at Karolinska
Clinical Trials Unit
DAPI
DIMDI
DIRC
DRFZ
DSRU
DVDS
Department of Clinical Epidemiology
Department of Epidemiology Lazio Region, Italy
Department of Public Health Sciences
Dept. of Epi. Research
Dpt Pharmacoepedemiology
Drugs and Pregnancy, THL
EPID Research
EPIDEMIOLOGY- DSMB - UDINE UNIVERSITY
Embryotox Berlin
Erasmus MC Pharmacoepi
Eurotrials
FICF
GISED
GPRD
Gillian Hall
HIPPOCRATES
HIRU
Haematology Oncology Leipzig
Health Search-SIMG
Hospital Clinic Barcelona
IADB.NL
IMS HEOR France
IMS Health Economics and Outcomes Research
IPRI
IRFMN
ISP Navarra
Instituto de Farmacoepidemiología
Kappa Santé
LA-SER Research
LSHTM
MAPI
MEMO
MFIR-Ulster
NCRR
NPEU
Netherlands Pharmacovigilance Centre Lareb
NorPD
OPED
OXON
OptumInsight
Outcome
P95
PAREXEL
PE2
PEL
PHARMO Institute
PVZ FAKOS
PWA
Paris Pharmacoepidemiology Centre
Patras Center for Pharmacoepidemiological studies
PhV Regional Centre of Lombardy, Italy
Pharmacoepidemiology INSERM 1027
Pharmacoepidemiology Research Group
Pharmacoepidemiology Unit - ISS
Pharmatelligence
Phisquare Institute
Prism
Quintiles Late Phase
RTI-HS
SER
SLC - The Human Motion Institute
Sicilian Pharmacovigilance Regional Centre
TCD Pharmacology & Therapeutics, Pharmacoepi group
TIS Helsinki
The School of Pharmacy, University of London
The Spanish DILI Registry
UFLVT
UFN
UFS
UNIBO
UPCET
University of Bath
Utrecht University Pharmacoepidemiology Center
Veneto Region Pharmacovigilance Centre
Wolfson Unit, Newcastle
ZEG Berlin
Other
Research Network:
ACRPV
AMSP
BIOBADASER
ENTIS
EUDRAGENE
EURAS/ INAS
EUROCAT
FIMP-MCRN
PGRx®
PRINTO
PROTECT
Psonet
RegiSCAR
ResearchLink
Other
Study drug
Substance Class (ATC Index):
e.g. C03 or diuretics
Substance (INN):
Brand Product Name:
Medical condition:
ENCePP Seal:
Yes
No
Population age:
Preterm newborns
Term newborns (0-27 days)
Infants and toddlers (28 days - 23 months)
Children (2 - 11 years)
Adolescents (12 - 17 years)
Adults (18 - 44 years)
Adults (45 - 64 years)
Adults (65 - 74 years)
Adults (75 years and over)
Other population:
Renal impaired
Hepatic impaired
Immunocompromised
Pregnant women
Scope of the Study:
Disease epidemiology
Risk assessment
Drug utilisation study
Effectiveness evaluation
Other
News
About Us
ENCePP Documents
Public Consultation
Glossary of terms
Code of Conduct
Standards and Guidances
ENCePP Studies
Resources Database
Partners forum
E-Register of Studies